The aim of the TOOLS colloquium is to create an interdisciplinary discussion forum that specifically bridges the gap between experimental optics and specific medical requirements. This new format focuses explicitly on the translational component - from optical fundamentals to application on (and for) patients.

1st TOOLS Colloquium
22.10.2025, 17:00 - 18:30
Ernst-Abbe-Hochschule Jena, Hörsaal 1
Free admission
hybrid: presence and online

We invite students, scientists, engineers and physicians to discuss current challenges, solutions and visions in the field of medically relevant photonics.

Focal points of the event series:

• New approaches in laser and imaging technologies for diagnostics and therapy.
• Co-operation between basic research, industry and clinical practice.
• Successful examples of the translation of optical technologies into medical technology.
• Exchange on current challenges and potentials in optics, biophotonics and medical technology.
• Live stream

The kick-off colloquium will take place on 22 October 2025 at 5 pm at the Ernst Abbe University of Applied Sciences Jena, Lecture Hall 1. The first speaker will be PD Dr Oliwia Makarewicz from Jena University Hospital, who will present current developments in the field of molecular diagnostics.

Microbiology in transition: innovative diagnostics and new therapies

Antimicrobial resistance (AMR) is one of the greatest global challenges facing modern medicine. While the development of new antibiotics is stagnating, complex infections caused by multi-resistant pathogens and biofilms are steadily increasing. Our Institute of Infection Medicine and Hospital Hygiene at Jena University Hospital pursues an interdisciplinary approach to address this problem holistically - from basic research to clinical application. The presentation will provide an insight into current projects and innovative strategies, including the use of nanopore sequencing for the rapid detection of pathogens and resistance genes, the integration of multi-omics data to create individual infection profiles, the development of personalised phage therapies and research into biofilm-associated infections and novel, antifouling-active materials. Finally, perspectives on personalised infection medicine will be presented and a discussion held on how these new diagnostic and therapeutic concepts can pave the way for more precise, patient-centred treatment approaches.

We look forward to lively networking between all players from research, clinical practice and industry!